Beacon Pointe Advisors »

Immunitybio shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $131k 26k 5.02
2023-09-30 $44k 26k 1.69

More positions owned by Beacon Pointe Advisors

Apple (AAPL)
Lennox International (LII)
Microsoft Corporation Put Option (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Mid Cap Etf (VO)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Value Etf (VTV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Amazon Call Option (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Beacon Pointe Advisors

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio